TAPROSTENE SODIUM(87440-45-7)
- Name: TAPROSTENE SODIUM
- Synonyms:
- Molecular Formula:C24H29NaO5
- Molecular Weight:420.4738
- CAS Registry Number:87440-45-7
- EINECS:
- Melting Point:173-182.5oC(lit.)
- Water Solubility:
CAS No.87440-45-7 TAPROSTENE SODIUM
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.87440-45-7 TAPROSTENE SODIUM
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.87440-45-7 TAPROSTENE SODIUM
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:TAPROSTENE SODIUM
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 71683-26-6/valproate phenacyl ester
- 68672-53-7/5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2Z)- (2-amino-4-thiazolyl)[(carboxymethoxy)imino]- acetyl]amino]-8-oxo-,disodium salt,(6R,7R)-
- 73043-48-8/4-[(4E)-2-methyl-5-oxo-4-(phenylmethylidene)-4,5-dihydro-1H-imidazol-1-yl]butanoic acid - piperazine (2:1)
- 80761-64-4/ISONICOTINIC ACID, 2-(6,8-DIOXO-5,6,7,8-TETRAHYDROPYRIMIDO(4,5-e)-as-TRIAZIN-3-Y
- 41458-65-5/6-AMINO-2,4-XYLENOL
- 97-45-0/(-)-CARVYL PROPIONATE
- 72571-82-5/Pipemidic acid trihydrate
- 63815-42-9/1-(4-ethoxyphenyl)-3-(piperidin-1-yl)propan-1-one hydrochloride (1:1)
- 66071-86-1/Soybean oil, polymer with isophthalic acid and pentaerythritol
- 41020-65-9/3-[(7R,8S,9S,10R,13R,14S)-7-(methoxycarbonyl)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl]propanoic acid (non-preferred name)
- 82905-09-7/8,10,12-Heptadecatriene-4,6-diyne-1,14-diol
- 51354-32-6/Nisterime
- 70879-61-7/Urea, reaction products with diethylene glycol and formaldehyde
- 5076-19-7/2,3-EPOXY-2-METHYLBUTANE
- 7033-00-3/3-(furan-2-yl)-3-(piperidin-1-yl)propan-1-ol
- 85209-66-1/2-[4-(1H-pyrrol-1-yl)phenyl]-N-1,3-thiazol-2-ylacetamide
- 84468-17-7/H-9 2HCL
- 30389-87-8/2-chloro-N-(2-chloroethyl)-N-(4-ethylbenzyl)ethanamine
- 38656-58-5/2,5-diethoxy-4-[(4-methylbenzoyl)amino]benzenediazonium tetrachlorozincate (2:1)
- 87440-45-7/TAPROSTENE SODIUM
- 102612-99-7/Undecanamide,11,11'-dithiobis[N-[(4-hydroxy-3-methoxyphenyl)methyl]- (9CI)
- 1069-00-7/D-glycero-D-gulo-Heptitol,rel-
- 41737-15-9/2-(2-(Dimethyl(3-(trimethyl-.lambda.~5~-azanyl)propyl)-.lambda.~5~-azanyl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione
- 619-27-2/3-Nitrophenylhydrazine
- 37517-33-2/Esproquine
- 521-88-0/KARANJIN
- 62391-99-5/VALPROIC ACID RELATED COMPOUND B (50 MG) ((2RS)-2-(1-METHYLETHYL)PENTANOIC ACID) (AS)
- 148297-92-1/pyroglutamyl-leucyl-glycyl-arginyl-phenylalaninamide
- 51618-40-7/1-methyl-5-[(4-methylphenyl)disulfanyl]-1H-tetrazole
- 1081-73-8/N-[2-(4-Bromophenoxy)ethyl]pyrrolidine